Philip Scumpia

8PUBLICATIONS
67CO-AUTHORS
Molecular targetsTissue engineeringCancer therapy (excl. chemotherapy and radiation therapy)Air pollution modelling and controlWearable materials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 21, 2026
Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1.

|Aug 09, 2024
Hydrogel crosslinking modulates macrophages, fibroblasts, and their communication, during wound healing.

Sergei Butenko, Raji R Nagalla, Christian F Guerrero-Juarez

|Feb 09, 2024
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes.

Sameeha Jilani, Justin D Saco, Edurne Mugarza

|Aug 17, 2023
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial.

Ari VanderWalde, Shay L Bellasea, Kari L Kendra

|Apr 27, 2023
Multi-organ landscape of therapy-resistant melanoma.

Sixue Liu, Prashanthi Dharanipragada, Shirley H Lomeli

|Nov 05, 2022
Parkin regulates adiposity by coordinating mitophagy with mitochondrial biogenesis in white adipocytes.

Timothy M Moore, Lijing Cheng, Dane M Wolf

Pageof 2

Frequent Collaborators

3 joint publications

Antoni Ribas

3 joint publications

Douglas B Johnson

2 joint publications

Alexandra P Ikeguchi

2 joint publications

Sapna P Patel